Literature DB >> 1721055

Structure and function studies of the cGMP-stimulated phosphodiesterase.

S D Stroop1, J A Beavo.   

Abstract

Studies of cGMP binding to both the native cyclic GMP-stimulated phosphodiesterase and to two unique isolated chymotryptic fragments lacking the catalytic domain suggest that the enzyme contains two noncatalytic cGMP-binding sites/homodimer. In the presence of high concentrations of ammonium sulfate, 2 mol of cGMP are bound/mol of cGMP-stimulated phosphodiesterase homodimer. Under these conditions, linear Scatchard plots of binding are obtained that give an apparent Kd of approximately 2 microM. The inclusion of 3-isobutyl-1-methylxanthine produces a curvilinear plot. In the absence of ammonium sulfate, the dissociation of cGMP from the holoenzyme is rapid, having a t1/2 of less than 10 s, and addition of ammonium sulfate to the incubation greatly decreases this rate of dissociation. The native enzyme is resistant to degradation by chymotrypsin in the absence of cGMP; however, in its presence, chymotrypsin treatment produces several discrete fragments. Similarly, in the presence but not in the absence of cGMP, dicyclohexylcarbodiimide causes an irreversible activation of the enzyme without cross-linking the nucleotide to the phosphodiesterase. Both observations provide evidence that a different conformation in the enzyme results from cGMP binding. Only the conformation formed upon cGMP binding is easily attacked by chymotrypsin or permanently activated by treatment with dicyclohexylcarbodiimide. One major chymotryptic cleavage site exposed by cGMP binding is at tyrosine 553, implying that this region takes part in the conformational change. Limited proteolysis experiments indicate that these noncatalytic binding sites are located within a region of internal sequence homology previously proposed to include the cGMP-binding site(s) and that they retain a high affinity and specificity for cGMP independent of the catalytic domain of the enzyme. The products formed by partial proteolysis can be separated into individual catalytically active and cGMP-binding fractions by anion exchange chromatography. Gel filtration and electrophoresis analysis of the isolated fractions suggest that the cGMP-binding peak has a dimeric structure. Moreover, it can be further resolved by polyethyleneimine high performance liquid chromatography into two peaks (Peaks IIIA and IIIB). Peak IIIA binds 2 mol of cGMP/mol of dimer with an apparent Kd of 0.2 microM. Peak IIIB, however, has greatly reduced cGMP binding. Further digestion of these fragments with cyanogen bromide show that the differences between Peaks IIIA and IIIB are due to one or more additional proteolytic nicks in IIIB that remove a few residues near its C terminus, most probably residues 523-550 or 534-550. This in turn suggests that this region is essential for cGMP-binding activity.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721055

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5.

Authors:  Ronald Jäger; Frank Schwede; Hans-Gottfried Genieser; Doris Koesling; Michael Russwurm
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor.

Authors:  Y S Ho; L M Burden; J H Hurley
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

3.  The distribution of phosphodiesterase 2A in the rat brain.

Authors:  D T Stephenson; T M Coskran; M P Kelly; R J Kleiman; D Morton; S M O'Neill; C J Schmidt; R J Weinberg; F S Menniti
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

4.  Solution structure of the cGMP binding GAF domain from phosphodiesterase 5: insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change.

Authors:  Clemens C Heikaus; Joseph R Stout; Monica R Sekharan; Catherine M Eakin; Ponni Rajagopal; Peter S Brzovic; Joseph A Beavo; Rachel E Klevit
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

5.  Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct.

Authors:  Jayvardhan Pandit; Michael D Forman; Kimberly F Fennell; Keith S Dillman; Frank S Menniti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-14       Impact factor: 11.205

6.  The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.

Authors:  Sergio E Martinez; Albert Y Wu; Natalie A Glavas; Xiao-Bo Tang; Stewart Turley; Wim G J Hol; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

7.  Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion.

Authors:  I C Green; C A Delaney; J M Cunningham; V Karmiris; C Southern
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

8.  PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling.

Authors:  Stefania Monterisi; Miguel J Lobo; Craig Livie; John C Castle; Michael Weinberger; George Baillie; Nicoletta C Surdo; Nshunge Musheshe; Alessandra Stangherlin; Eyal Gottlieb; Rory Maizels; Mario Bortolozzi; Massimo Micaroni; Manuela Zaccolo
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140

9.  Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy.

Authors:  Miguel J Lobo; Laia Reverte-Salisa; Ying-Chi Chao; Andreas Koschinski; Frank Gesellchen; Gunasekaran Subramaniam; He Jiang; Samuel Pace; Natasha Larcom; Ester Paolocci; Alexander Pfeifer; Sara Zanivan; Manuela Zaccolo
Journal:  Commun Biol       Date:  2020-10-21

10.  Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor.

Authors:  Meghana Manjunath; Sai Swaroop; Sai Sanwid Pradhan; Raksha Rao K; Raghunandan Mahadeva; Venketesh Sivaramakrishnan; Bibha Choudhary
Journal:  Genes (Basel)       Date:  2022-07-06       Impact factor: 4.141

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.